Genenta Science S.p.A. (GNTA) vs Harte Hanks (HHS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Harte Hanks (HHS) has outperformed Genenta Science S.p.A. (GNTA) over the past year, gaining 24.6% versus a loss of 78.4%. Genenta Science S.p.A. is the larger company by market cap ($34.2 million vs $33.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNTA | HHS |
|---|---|---|
| Share price | $0.7101 | $4.45 |
| Market cap | $34.24M | $33.17M |
| 1-day change | -5.95% | +1.14% |
| YTD return | -52.34% | +47.84% |
| 1-year return | -78.35% | +24.65% |
| 5-year return | — | -35.97% |
| EPS (TTM) | $-0.37 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $4.67 |
| 52-week low | $0.55 | $2.00 |
| Distance from 52-week high | -92.90% | -4.71% |
| Average volume | 61.46K | 160.32K |
| Shares outstanding | 48.22M | 7.45M |
| Employees | 9 | 1,719 |
| Sector | Industrials | Industrials |
| Industry | Conglomerates | Conglomerates |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HHS has outperformed GNTA by 103.0 percentage points over the past year.
About Genenta Science S.p.A.
GNTA stock →Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Industrials · Conglomerates · 9 employees
About Harte Hanks
HHS stock →Harte Hanks, Inc. operates as a customer experience company in the United States and internationally.
Industrials · Conglomerates · 1,719 employees
GNTA vs HHS FAQ
Which is bigger, Genenta Science S.p.A. or Harte Hanks?
Genenta Science S.p.A. (GNTA) is larger, with a market capitalization of $34.24M compared with $33.17M for Harte Hanks (HHS).
Which stock has performed better over the past year, GNTA or HHS?
HHS returned +24.65% over the past 12 months, compared with -78.35% for GNTA (price return, excluding dividends). Past performance does not predict future results.
Are Genenta Science S.p.A. and Harte Hanks in the same industry?
Yes. Both are classified in the Conglomerates industry within the Industrials sector.